Tenascin-C drives persistence of organ fibrosis

Nature Communications

Volumn 7, Issue , 2016, Pages

  Bhattacharyya, Swati ^a   Wang, Wenxia ^a   Morales Nebreda, Luisa ^a   Feng, Gang ^a   Wu, Minghua ^b   Zhou, Xiaodong ^b   Lafyatis, Robert ^c   Lee, Jungwha ^a   Hinchcliff, Monique ^a   Feghali Bostwick, Carol ^d   Lakota, Katja ^a   Budinger, G R Scott ^a   Raparia, Kirtee ^a   Tamaki, Zenshiro ^a   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TENASCIN; TOLL LIKE RECEPTOR 4;

COLLAGEN; GENE EXPRESSION; PHYSIOLOGICAL RESPONSE; RODENT; SERUM; SKIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LUNG FIBROSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN FIBROBLAST; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; UPREGULATION; ADULT; AGED; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CELL DIFFERENTIATION; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN;

MUS;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; MICE; MIDDLE AGED; MYOFIBROBLASTS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN; TENASCIN; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84973360161     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11703     Document Type: Article

References (65)

1. Rockey, D. C., Bell, P. D. & Hill, J. A. Fibrosis-a common pathway to organ injury and failure. N. Engl. J. Med. 372, 1138-1149 (2015).
2. Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8, 42-54 (2012).
3. Johnson, M. E. et al. Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts. PloS One 10, e0114017 (2015).
4. Johnson, M. E., Pioli, P. A. & Whitfield, M. L. Gene expression profiling offers insights into the role of innate immune signaling in SSc. Semin. Immunopathol. 37, 501-509 (2015).
5. Piccinini, A. M. & Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 1-21 (2010).
6. Giblin, S. P. & Midwood, K. S. Tenascin-C: form versus function. Cell Adh. Migr. 9, 48-82 (2015).
7. Udalova, I. A., Ruhmann, M., Thomson, S. J. & Midwood, K. S. Expression and immune function of tenascin-C. Crit. Rev. Immunol. 31, 115-145 (2011).
8. Pendergrass, S. A. et al. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J. Invest. Dermatol. 132, 1363-1373 (2012).
9. Milano, A. et al. Molecular subsets in the gene expression signatures of scleroderma skin. PloS One 3, e2696 (2008).
10. Dang, C. et al. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br. J. Dermatol. 155, 763-770 (2006).
11. Brissett, M., Veraldi, K. L., Pilewski, J. M., Medsger, Jr T. A. & Feghali- Bostwick, C. A. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum. 64, 272-280 (2012).
12. Nishio, T. et al. Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay. Neuroscience 132, 87-102 (2005).
13. Bhattacharyya, S. et al. FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci. Transl. Med. 6, 232ra250 (2014).
14. Midwood, K. et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774-780 (2009).
15. Machino-Ohtsuka, T. et al. Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation. J. Am. Heart Assoc. 3, e001052 (2014).
16. Nakao, N., Hiraiwa, N., Yoshiki, A., Ike, F. & Kusakabe, M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am. J. Pathol. 152, 1237-1245 (1998).
17. Koyama, Y. et al. Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J. Invest. Dermatol. 111, 930-935 (1998).
18. Matsuda, A., Yoshiki, A., Tagawa, Y., Matsuda, H. & Kusakabe, M. Corneal wound healing in tenascin knockout mouse. Invest. Ophthalmol. Vis. Sci. 40, 1071-1080 (1999).
19. Mackie, E. J. & Tucker, R. P. The tenascin-C knockout revisited. J. Cell Sci. 112(Pt 22): 3847-3853 (1999).
20. Williamson, J. D., Sadofsky, L. R. & Hart, S. P. The pathogenesis of bleomycininduced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp. Lung Res. 41, 57-73 (2015).
21. Wu, M. et al. Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am. J. Pathol. 175, 1041-1055 (2009).
22. Roth-Kleiner, M., Hirsch, E. & Schittny, J. C. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am. J. Respir. Cell Mol. Biol. 30, 360-366 (2004).
23. Sheppard, D. Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-beta activation by epithelial cells and fibroblasts. Ann. Am. Thorac. Soc. 12(Suppl 1): S21-S23 (2015).
24. Maki, J. M. Lysyl oxidases in mammalian development and certain pathological conditions. Histol. Histopathol. 24, 651-660 (2009).
25. Nihtyanova, S. I. et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol. 66, 1625-1635 (2014).
26. Siracusa, L. D. et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6, 300-313 (1996).
27. Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Prim. 1, 1-21 (2015).
28. Mahoney, J. M. et al. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput. Biol. 11, e1004005 (2015).
29. Bhattacharyya, S. et al. Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 182, 192-205 (2013).
30. Stifano, G. et al. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res. Ther. 16, R136 (2014).
31. Bhattacharyya, S. & Varga, J. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis. Curr. Rheumatol. Rep. 17, 474 (2015).
32. O'Reilly, S. Innate immunity in systemic sclerosis pathogenesis. Clin. Sci. 126, 329-337 (2014).
33. Farina, A. et al. Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J. Invest. Dermatol. 134, 954-964 (2014).
34. Arron, S. T. et al. High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis. J. Invest. Dermatol. 134, 2138-2145 (2014).
35. Fineschi, S. et al. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. Arthritis Rheum. 58, 3913-3923 (2008).
36. O'Reilly, S. Pound the alarm: danger signals in rheumatic diseases. Clin. Sci. 128, 297-305 (2015).
37. Bryant, C. E. et al. Advances in Toll-like receptor biology: modes of activation by diverse stimuli. Crit. Rev. Biochem. Mol. Biol. 50, 359-379 (2015).
38. Schaefer, L. Proteoglycans, key regulators of cell-matrix dynamics. Matrix Biol. 35, 1-2 (2014).
39. Kasprzycka, M., Hammarstrom, C. & Haraldsen, G. Tenascins in fibrotic disorders-from bench to bedside. Cell Adh. Migr. 9, 83-89 (2015).
40. Carey, W. A., Taylor, G. D., Dean, W. B. & Bristow, J. D. Tenascin-C deficiency attenuates TGF-ss-mediated fibrosis following murine lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L785-L793 (2010).
41. Shimojo, N. et al. Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin alphaVbeta3/nuclear factor-kappaB/interleukin-6 axis. Hypertension 66, 757-766 (2015).
42. El-Karef, A. et al. Deficiency of tenascin-C attenuates liver fibrosis in immunemediated chronic hepatitis in mice. J. Pathol. 211, 86-94 (2007).
43. Sumioka, T. et al. Impaired cornea wound healing in a tenascin C-deficient mouse model. Lab. Invest. 93, 207-217 (2013).
44. Estany, S. et al. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFbeta1. BMC Pulm. Med. 14, 120 (2014).
45. Dalkowski, A., Schuppan, D., Orfanos, C. E. & Zouboulis, C. C. Increased expression of tenascin C by keloids in vivo and in vitro. Br. J. Dermatol. 141, 50-56 (1999).
46. Wells, A., Nuschke, A. & Yates, C. C. Skin tissue repair: matrix microenvironmental influences. Matrix Biol. 49, 25-36 (2015).
47. Midwood, K. S. & Orend, G. The role of tenascin-C in tissue injury and tumorigenesis. J. Cell Commun. Signal. 3, 287-310 (2009).
48. Tucker, R. P. & Chiquet-Ehrismann, R. Tenascin-C: its functions as an integrin ligand. Int. J. Biochem. Cell Biol. 65, 165-168 (2015).
49. Fujimoto, M. et al. Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol. Dis. 55, 104-109 (2013).
50. Kuriyama, N., Duarte, S., Hamada, T., Busuttil, R. W. & Coito, A. J. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology 54, 2125-2136 (2011).
51. Liu, R. et al. Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4. Mol. Cells 34, 35-41 (2012).
52. de Haan, J. J., Smeets, M. B., Pasterkamp, G. & Arslan, F. Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm. 2013, 206039 (2013).
53. Forsberg, E. et al. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl Acad. Sci. USA 93, 6594-6599 (1996).
54. Tamaoki, M. et al. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am. J. Pathol. 167, 71-80 (2005).
55. Mokone, G. G. et al. The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with achilles tendon injuries. Am. J. Sports Med. 33, 1016-1021 (2005).
56. Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A. & Sakakura, T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139 (1986).
57. Schreiber, J., Schachner, M., Schumacher, U. & Lorke, D. E. Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice. Acta Histochem. 115, 865-878 (2013).
58. Goh, F. G., Piccinini, A. M., Krausgruber, T., Udalova, I. A. & Midwood, K. S. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J. Immunol. 184, 2655-2662 (2010).
59. Kimura, T. et al. Tenascin C protects aorta from acute dissection in mice. Sci. Rep. 4, 4051 (2014).
60. Masi, A.T. and subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23, 581-590 (1980).
61. Simpson, C. L., Kojima, S. & Getsios, S. RNA interference in keratinocytes and an organotypic model of human epidermis. Methods Mol. Biol. 585, 127-146 (2010).
62. Getsios, S. et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J. Cell Biol. 185, 1243-1258 (2009).
63. Hubner, R. H. et al. Standardized quantification of pulmonary fibrosis in histological samples. BioTechniques 44, 507-517 (2008).
64. dos Santos, G. et al. Vimentin regulates activation of the NLRP3 inflammasome. Nat. Commun. 6, 6574 (2015).
65. Urich, D. et al. Lung-specific loss of the laminin alpha3 subunit confers resistance to mechanical injury. J. Cell Sci. 124, 2927-2937 (2011).